Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019.
J Occup Environ Med
; 66(3): 226-233, 2024 Mar 01.
Article
em En
| MEDLINE
| ID: mdl-38151973
ABSTRACT
OBJECTIVE:
The aim of the study is to estimate the association between productivity losses and the use of prescription opioids and benzodiazepines among employed US adults with painful conditions.METHODS:
Using Medical Expenditures Panel Survey (2010-2019), we used two-part (logistic regression and generalized linear model with zero-truncated negative binomial link) model to compare missed workdays due to illness or injury among employed adults with a painful condition.RESULTS:
Of the eligible sample of 57,413 working US individuals, 14.65% were prescription opioid users, 2.95% were benzodiazepine users, and 1.59% were both opioid and benzodiazepine users. The predicted missed workdays were 5.75 (95% Confidence Limit [CL] 5.58-5.92) days for benzodiazepine users, 13.06 (95% CL 12.88-13.23) days among opioid users, and 15.18 (95% CL 14.46-15.90) days for opioid and benzodiazepine concomitant users.CONCLUSIONS:
Concomitant use of prescription opioids and benzodiazepines was significantly associated with having more missed workdays among employed adults with documented painful conditions.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Benzodiazepinas
/
Analgésicos Opioides
Limite:
Adult
/
Humans
País como assunto:
America do norte
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article